全文获取类型
收费全文 | 1034篇 |
免费 | 0篇 |
专业分类
电工技术 | 1篇 |
化学工业 | 7篇 |
机械仪表 | 2篇 |
轻工业 | 9篇 |
无线电 | 5篇 |
一般工业技术 | 3篇 |
冶金工业 | 1003篇 |
原子能技术 | 2篇 |
自动化技术 | 2篇 |
出版年
2021年 | 2篇 |
2018年 | 3篇 |
2017年 | 1篇 |
2013年 | 1篇 |
2012年 | 2篇 |
2011年 | 1篇 |
2010年 | 2篇 |
2008年 | 4篇 |
2007年 | 1篇 |
2005年 | 1篇 |
2004年 | 3篇 |
2003年 | 5篇 |
2002年 | 3篇 |
2000年 | 2篇 |
1999年 | 32篇 |
1998年 | 289篇 |
1997年 | 165篇 |
1996年 | 116篇 |
1995年 | 79篇 |
1994年 | 47篇 |
1993年 | 54篇 |
1992年 | 10篇 |
1991年 | 21篇 |
1990年 | 18篇 |
1989年 | 20篇 |
1988年 | 22篇 |
1987年 | 15篇 |
1986年 | 20篇 |
1985年 | 11篇 |
1982年 | 9篇 |
1981年 | 3篇 |
1980年 | 9篇 |
1979年 | 1篇 |
1978年 | 3篇 |
1977年 | 13篇 |
1976年 | 41篇 |
1975年 | 3篇 |
1964年 | 1篇 |
1955年 | 1篇 |
排序方式: 共有1034条查询结果,搜索用时 15 毫秒
11.
KW Scheller J G?rres JG Ross M Wiescher R Harkewicz DJ Morrissey BM Sherrill M Steiner NA Orr JA Winger 《Canadian Metallurgical Quarterly》1994,49(1):46-50
The shortage of suitable liver donors for children has motivated the use of ABO-incompatible (ABO-I) grafts for transplantation in urgent situations. However, survival after ABO-I liver grafts has been reported at about 30% as compared with 80% in cases of ABO-identical or -compatible liver grafts. This difference has been attributed to antibody-mediated, hyperacute or chronic liver rejection, due to preformed ABO antibodies (alloantibodies). In this study, we report our results with ABO-I livers in children without alloantibodies at the time of transplantation. From January 1988 to June 1993, 143 OLT were performed in 122 children. Eight children received 8 ABO-I liver grafts. Of these, 7 patients were included in the study. All 7 were alloantibody free before OLT. Five children were spontaneously alloantibody free, while in 2 children, the plasma alloantibodies were eliminated before and after transplantation using intravenous infusion of specific blood group antigens of the donor blood group (soluble antigens). Immunosuppression consisted of a triple-drug treatment combining CsA, AZA, and steroids. The follow-up period was between 10 and 48 months. One child died from a surgical complication. Six children survived, but 1 died 10 months later from intestinal obstruction. There were no graft losses and no episodes of hyperacute or chronic rejection. The graft and patient survival rate was 71%. There was a 28% incidence of rejection, but all were mild (requiring steroid boluses only). Our results suggest that the absence of ABO alloantibodies at the time of and after transplantation can protect ABO-I liver grafts against antibody-mediated rejection, whether hyperacute or chronic, and that soluble antigens are effective in eliminating alloantibodies in children. 相似文献
12.
KW Preidler G Ranner D Szolar C Walch W Anderhuber 《Canadian Metallurgical Quarterly》1996,38(4):378-380
Ganglioneuroma, a rare benign tumour, very occasionally presents in adult life. We report a case with the additional unusual feature of a retropharyngeal location. 相似文献
13.
Retroviral display of antibody fragments; interdomain spacing strongly influences vector infectivity 总被引:1,自引:0,他引:1
S Ager BH Nilson FJ Morling KW Peng FL Cosset SJ Russell 《Canadian Metallurgical Quarterly》1996,7(17):2157-2164
Five different single-chain antibody fragments (scFv) against human cell-surface antigens were displayed on murine ecotropic retroviral vectors by fusing them to the Moloney SU envelope glycoprotein. The spacing between the scFv and the SU glycoprotein was varied by fusing the scFv to residue +7 or to residue +1 of Moloney SU and by inserting linker sequences of different lengths between the domains. All of the chimeric envelopes were efficiently incorporated into vector particles and could bind to human cells through their displayed antibody fragments, but did not infect them. The spacing between the scFvs and the SU glycoproteins had no significant effect on the efficiency of envelope expression or viral incorporation and did not affect the binding properties of the chimeric envelopes, nor did it influence the efficiency of targeted gene delivery to human cells by scFv-displaying vectors. However, on murine fibroblasts the infectivity of vectors incorporating the chimeric envelopes was strongly influenced by the length of the interdomain spacer. The titers were very low when the single-chain antibodies were fused through a tripeptide linker to SU residue +7 and were greatly enhanced (up to 10(5)-fold) when they were fused to SU residue +1 through a heptapeptide linker. These results point to the importance of steric interactions between the domains of chimeric envelope glycoproteins and may have implications for retroviral vector design for human gene therapy. 相似文献
14.
15.
SW Mamber B Kolek KW Brookshire DP Bonner J Fung-Tomc 《Canadian Metallurgical Quarterly》1993,37(2):213-217
Eight quinolones were examined for their bacterial mutagenicity in the Ames Salmonella TA102 assay and for their effects in other bacterial genotoxicity assays. In the quantitative Ames plate incorporation assay, all eight quinolones induced His+ deletion reversion in Salmonella tester strain TA102, with maximum reversion observed at about two to eight times the MIC. The quinolones also induced the SOS response. At quinolone concentrations close to the MIC, SOS cell filamentation gene sulA was induced in sulA::lacZ fusion strain Escherichia coli PQ37. RecA-mediated cleavage of lambda repressor in lambda::lacZ fusion strain E. coli BR513 was measurable at about 10 times the MIC, though no induction occurred at 20 micrograms of nalidixic or oxolinic acid per ml. Genotoxicity of quinolones also was observed in the Bacillus subtilis DNA repair assay, in which the mutant strain M45 (recA) was more susceptible to quinolones than its parent strain, H17 (rec+). The results from these analyses indicate that quinolones induce SOS functions and are mutagenic in bacteria; these properties correspond to their antimicrobial activities. 相似文献
16.
17.
18.
19.
Six adult patients with cleft palate, ranging in age from 47 to 78 years, were treated with self-tapping titanium implants. Twenty-three implants, 7 to 15 mm in length, were placed. Of these, one (4%) was 7 mm, eight (35%) were 10 mm, nine (39%) were 13 mm, and five (22%) were 15 mm. Time between stage I and stage II implant surgeries was 5 to 14 months, averaging 8.3 months. Time from stage II surgery to the present is 1.5 to 5 years, averaging 3 years. Of the 23 implants placed, 21 (91%) achieved osseointegration. One (4%) implant was not used prosthetically. Two (9%) 10 mm implants failed to integrate in one patient. All patients were treated with a maxillary complete denture or overdenture. Five (83%) required the addition of a pharyngeal section for speech enhancement. 相似文献
20.